Home|Journals|Articles by Year|Audio Abstracts
 

Original Research

Med Arch. 2013; 67(3): 202-204


Does Oxybutynin Hydrochloride Cause Arrhythmia in Children with Bladder Dysfunction?

Ilhan Ciftci, Derya Arslan, Harun Peru, Derya Cimen, Bulent Oran, Metin Gunduz.




Abstract

Aim: Pediatric surgeons frequently encounter children presenting with voiding dysfunction symptoms, including urgency, frequency, and incontinence. Antimuscarinic agents (Oxybutynin) are the main drugs used to treat patients with overactive bladder (OAB) syndrome, defined as urgency, with or without urgency incontinence, usually with increased daytime frequency and nocturia. Increased QT dispersion is known to be the cause of ventricular arrhythmia in various systemic diseases and leads to increased mortality and morbidity. Method: This study represents a subset of a complete data set, considering only those children aged admitted to the Pediatric Surgery and Pediatric Nephrology Clinics during the period January 2011 to July 2012. Result: In this study, we have determined that the QT interval changes significantly depending on the use of oxybutynin. The QT changes increased cardiac arrhythmia in children. Conclusion: For this reason, children using such drugs should be closely monitored for cardiac arrhythmia.

Key words: cholinergic antagonists; oxybutynin; urinary incontinence; overactive bladder; children; QT interval.






Full-text options


Share this Article


Online Article Submission
• ejmanager.com




ejPort - eJManager.com
Refer & Earn
JournalList
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.